Skip to main content

Table 1 Comparison of the patients’ baseline characteristics between two groups

From: Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial

Variables

Group A

(Prolutex)

(n = 40)

Group B

(Cyclogest)

(n = 40)

p-value

Women’s age (years)

31.7 ± 4.6

32.7 ± 3.7

0.26

Body mass index (kg/m2)

24.0 ± 3.0

25.4 ± 2.9

0.08

The serum level of AMH (ng/ml)

3.1 ± 1.8

2.4 ± 1.2

0.08

The basal level of FSH (IU/l)

6.0 ± 2.0

6.5 ± 2.7

0.08

The basal level of LH (IU/l)

4.9 ± 2.7

4.7 ± 2.3

0.76

Infertility duration (years)

5/2 ± 6/4

8/3 ± 5/4

0.98

The cause of infertility, n (%)

  

0.46

Male factor

23 (57.5)

27 (67.5)

 

Unexplained factor

14 (35)

9 (22.5)

 

Tubal factor

3 (7.5)

4 (10)

 

Type of infertility, n (%)

  

0.75

Primary

35 (87.5)

33 (82.5)

 

Secondary

5 (12.5)

7 (17.5)

 
  1. AMH, anti-Müllerian hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; IU, international unit. P-value less than 0.05, there was a significant difference between groups